PDF herunterladen
Pharmacopsychiatry 2004; 37(4): 191-192
DOI: 10.1055/s-2004-827177
Letter
© Georg Thieme Verlag KG Stuttgart · New York

Tramadol Use and Dependence in Chronic Noncancer Pain Patients

M. Soyka1 , M. Backmund2 , S. Hasemann1
  • 1Psychiatric Hospital University of Munich, München, Germany
  • 2Krankenhaus München Schwabing, München,· Germany
Weitere Informationen

Publikationsverlauf

Received: 16.1.2003 Revised: 9.5.2003

Accepted: 5.6.2003

Publikationsdatum:
01. Juli 2004 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Over a two year period, we have seen 20 cases with physical dependence of tramadol, 17 of them had initially received tramadol for chronic noncancer pain. Clinical characteristics of these patients are given. Twelve of them (60 %) did not complete detoxification, indicating this to be a difficult patient group.

References

  • 1 Brinker A, Bonnel R A, Beitz J. Abuse, dependence, withdrawal associated with tramadol (letter).  Am J Psychiatry. 2002;  159 881
    CrossrefPubMedGoogle Scholar
  • 2 Cicero T J, Adams E H, Giller H, Inciardi J A, Monoz A, Schnoll S H, Senay E Z, Woody G E. A post marketing surveillance programme to monitor ultram (tramadol hydrochloride) abuse in the United States.  Drug Alcohol Depend. 1999;  57 7-22
    CrossrefPubMedGoogle Scholar
  • 3 Dertwinkel R, Wiebalck A, Zenz M, Strumpf M. Oral opioids for long-term treatment of chronic non-cancer pain (in German).  Anaesthesist. 1996;  45 495-505
    CrossrefPubMedGoogle Scholar
  • 4 Dunbar S A, Katz N P. Chronic opioid therapy for nonmalignant pain in patients with a history of substance abuse: report of 20 cases.  J Pain Symptom Manag. 1996;  11 163-171
    PubMedGoogle Scholar
  • 5 Gostomzyk J G, Heller W -D. Long-term use of narcotics in pain (in German).  Dtsch Med Wochenschr. 1990;  115 763-770
    PubMedGoogle Scholar
  • 6 Grond S, Meuser T, Zech D, Henning U, Lehmann K A. Analgesic efficacy and safety of tramadol enentiomers in comparison with racemate: a randomised, double-blind study with gynecological patients using intravenous patient-controlled analgesia.  Pain. 1995;  62 313-320
    CrossrefPubMedGoogle Scholar
  • 7 Joranson D E, Ryan K M, Gilson A M, Dahl J P. Trends in medical use and abuse of opioid analgesics.  JAMA. 2000;  283 1710-1714
    CrossrefPubMedGoogle Scholar
  • 8 Kanner R. Opioids for chronic pain: issues is efficacy, not addiction.  Neurol Net Commun. 1998;  2 175-179
    PubMedGoogle Scholar
  • 9 Keup W. Mißbrauchsmuster 1998. Frühwarnsystem-Daten für die Bundesrepublik Deutschland 1976-1998. Starnberg; 1999
    Google Scholar
  • 10 Kouynaou K, Pither C E, Rabe-Hesketh S, Wessely S. A comparative study of Iatrogenesis, medication abuse and psychiatric morbidity in chronic pain patients with and without medically explained symptoms.  Pain. 1998;  76 417-426
    CrossrefPubMedGoogle Scholar
  • 11 Kouyanou K, Pither C E, Wesseley S. Medication misues, abuse and dependence in chronic pain patients.  J Psychosom Res. 1997;  43 497-504
    CrossrefPubMedGoogle Scholar
  • 12 Lee C R, McTavish D, Sorkin E M. Tramadol: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states.  Drugs. 1993;  46 313-340
    PubMedGoogle Scholar
  • 13 Leo R J, Narendan R, DeGuiseppe B. Methadone detoxification of tramadol dependence.  J Subst Abuse Treat. 2000;  19 297-299
    CrossrefPubMedGoogle Scholar
  • 14 Phillipp M, Fickinger M. Psychotropic drugs in the management of chronic pain syndromes.  Pharmacopsychiatry. 1993;  26 221-234
    PubMedGoogle Scholar
  • 15 Preston K L, Jasinski R D, Testa M. Abuse potential and pharmacological comparison of tramadol and morphine.  Drug Alcohol Depend. 1991;  27 7-17
    PubMedGoogle Scholar
  • 16 Porter J, Jick H. Addiction rare in patients treated with narcotics.  N Engl J Med. 1980;  302 123-125
    PubMedGoogle Scholar
  • 17 Protenoy R K, Foley K M. Chronic use of opioid analgesics in nonmalignant pain: report of 38 cases.  Pain. 1986;  25 171-186
    CrossrefPubMedGoogle Scholar
  • 18 Quang-Cantagrel N D, Wallace M S, Manuson S K. Opioid substitution to improve the effectiveness of chronic noncancer pain control: a chart review.  Anesth Analg. 2000;  90 933-937
    PubMedGoogle Scholar
  • 19 Radbruch L, Grond S, Lehmann K A. A risk benefit assessment of tramadol in the management of pain.  Drug Saf. 1996;  15 8-29
    PubMedGoogle Scholar
  • 20 Roider G, Drasch G, v Meyer L, Sachs H. Tramadol als Drogenersatz.  DAZ. 2000;  140 3373-3375
    PubMedGoogle Scholar
  • 21 Russel K, Portenoy M D. Opioid therapy for nonmalignant pain: a review of the critical issues.  J Pain Symptom Manag. 1996;  11 203-217
    PubMedGoogle Scholar
  • 22 Schmidt-Kittler H, v Meyer L. Drogenbedingte Todesfälle 1998. Suchtmed 2000: 103-109
    Google Scholar
  • 23 Wambach S, Rohr P, Häuser W. Abuse of opioid therapie in somatoform pain disorder. A contribution from a psychosomatic/ pain therapist point of view to the discussion of the indication of opioids in nonmalignant pain based on 8 cases (in German).  Schmerz. 2001;  15 254-264
    CrossrefPubMedGoogle Scholar
  • 24 Yates W R, Nguyen M H, Warnock Y K. Tramadol dependence with no history of substance abuse.  Am J Psychiatry. 2001;  158 964
    PubMedGoogle Scholar

Michael Soyka

Psychiatric Hospital University of Munich

Nußbaumstr. 7

80336 München

Germany

eMail: Michael.Soyka@psy.med.uni-muenchen.de